About this Course
UConn has developed web-based continuing pharmacy education activities to enhance the practice of pharmacists and assist pharmacists in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve. There are a total of 17.25 hours of CPE credit available. Successful completion of these 17.25 hours (13 activities) or equivalent training will prepare the pharmacist for the Anticoagulation Traineeship, which described below in the Additional Information Box.
The activities below are available separately for $17/hr or as a bundle price of $199 for all 13 activities (17.25 hours). These are the pre-requisites for the anticoagulation traineeship. Any pharmacist who wishes to increase their knowledge of anticoagulation may take any of the programs below.
When you are ready to submit quiz answers, go to the Blue "Take Test/Evaluation" Button.
Target Audience
Pharmacists who are interested in making sound clinical decisions to affect the outcome of anticoagulation therapy for the patients they serve.
This activity is NOT accredited for technicians.
Pharmacist Learning Objectives
At the completion of this activity, the participant will be able to:
|
|
|
|
Release Date
Released: 07/15/2025
Expires: 07/15/2028
Course Fee
$25.50
ACPE UAN Code
ACPE #0009-0000-25-036-H04-P
Session Code
25AC36-EXW48
Accreditation Hours
1.5 hours of CE
Bundle Options
If desired, “bundle” pricing can be obtained by registering for the activities in groups. This series consists of thirteen anticoagulation activities in our online selection.
You may register for individual topics at $17/CE Credit Hour, or for the Entire Anticoagulation Pre-requisite Series.
Pharmacist General Registration for 13 Anticoagulation Pre-requisite activities-(18.25 hours of CE) $199.00
In order to attend the 2-day Anticoagulation Traineeship, you must complete all of the Pre-requisite Series or the equivalent.
Additional Information
Anticoagulation Traineeship at the University of Connecticut Health Center, Farmington, CT
The University of Connecticut School of Pharmacy and The UConn Health Center Outpatient Anticoagulation Clinic have developed 2-day practice-based ACPE certificate continuing education activity for registered pharmacists and nurses who are interested in the clinical management of patients on anticoagulant therapy and/or who are looking to expand their practice to involve patient management of outpatient anticoagulation therapy. This traineeship will provide you with both the clinical and administrative aspects of a pharmacist-managed outpatient anticoagulation clinic. The activity features ample time to individualize your learning experience. A “Certificate of Completion” will be awarded upon successful completion of the traineeship.
Accreditation Statement
The University of Connecticut, School of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Statements of credit 1.5 hours (or 0.15 CEUS) for the online activity ACPE #0009-0000-25-036-H04-P will be awarded when the post test and evaluation have been completed and passed with a 70% or better. Your CE credits will be uploaded to your CPE monitor profile within 2 weeks of completion of the program.
Grant Funding
There is no grant funding for this activity.
Requirements for Successful Completion
To receive CE Credit go to Blue Button labeled "take Test/Evaluation" at the top of the page.
Type in your NABP ID, DOB and the session code for the activity. You were sent the session code in your confirmation email, and it is listed on this webpage above.
Faculty
Youssef Bessada, PharmD, BCPS, BCCP
Assistant Clinical Professor
UConn School of Pharmacy
Storrs, CT
Faculty Disclosure
In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity.
Dr. Bessada has no relationship with an ineligible company and therefore has nothing to disclose.
Disclaimer
This activity may contain discussion of off label/unapproved use of drugs. The content and views presented in this educational program are those of the faculty and do not necessarily represent those of the University of Connecticut School of Pharmacy. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Program Content
Program Handouts
Post Test Evaluation
View Questions for Anticoagulation Management Pearls
1. The Joint Commission revised National Patient Safety Goal is intended to:
a. Provide guidance on how to deal with providers and health systems who do not adhere to the standards
b. Set standards on provider’s level of knowledge of anticoagulant medications
c. Reduce the likelihood of patient harm associated with the use of anticoagulant therapy
2. Which of the following would be a key area where using a multidisciplinary approach to anticoagulation management is necessary?
a. Perioperative anticoagulation management
b. Dosing warfarin in an outpatient clinic
c. Identifying cost-barriers to DOAC management
3. What is a practical and efficient way to ensure that DOAC dosing errors are minimized upon initiation?
a. Implement a program where only pharmacists dose DOACs on discharge from the hospital
b. Ensure regular updates of dosing policies & protocols with a changing clinical landscape
c. Set an electronic medical record requirement for all DOAC discharge orders to be reviewed by the outpatient anticoagulation clinic
4. How are clinician decision support tools best used in the anticoagulation management clinical setting?
a. They should be leveraged to automate decision-making to reduce inter-provider variability
b. They should be leveraged to assist decision-making using standardized protocols and pathways to minimize errors
c. They should be leveraged to optimize decision-making and increase speed of discharges, clinic visits and decrease staff dependence
5. Which of the following is an evidence-based benefit of utilizing a population health model to optimize anticoagulation management?
a. Population health models have been linked to improved clinical outcomes and reduced times to intervention
b. Population health models have been linked to automating patient monitoring to decrease the need for clinician oversight
c. Population health models when combined with artificial intelligence will minimize the need for pharmacists in the future
6. Which of the strategies is best when managing patients with language barriers?
a. Ask patient to bring in family members who can help interpret
b. Ask bilingual coworker to help interpret
c. Use qualified interpreter
7. Which of the following would be the most appropriate depiction of transitions of care?
a. A transition of care anytime a patient’s clinical setting changes
b. A transition of care is handled solely by the hospital discharge staff
c. Provide transition of care assistance only to elderly patients who request it
8. Which of the following statements are true regarding transitioning between anticoagulants?
a. Transitions between anticoagulants should be done regularly to account for a patient’s changing clinical status, especially over time
b. Literature suggests that transitioning between anticoagulants inherently increases risk of bleeding and clotting, and should be done with care
c. All DOACs can be transitioned to and from warfarin and heparins using the same transition guidance
Additional Courses Available for Anticoagulation
Vitamin K Antagonist Pharmacology, Pharmacotherapy and Pharmacogenomics – 1 hour
Anticoagulation Management Pearls - 1.5 hour
Clinical Overview of Direct Oral Anticoagulants– 1.25 hour
Laboratory Monitoring of Anticoagulation – 2 hour
Heparin/Low Molecular Weight Heparin and Fondaparinux Pharmacology and Pharmacotherapy – 0.5 hours
Developing an Anticoagulation Clinic – 1.0 hour
Pharmacist Reimbursement for Anticoagulation Services – 0.5 hour
Risk Management in Anticoagulation – 1 hour
A Practical Approach to Perioperative Oral Anticoagulation Management – 2 hour
Management of Hypercoagulable States – 1.5 hour
Challenging Topics in Anticoagulation – 2 hour
Available Strategies to Reverse Anticoagulation Medications - 2 hour
Drug Interaction Cases with Anticoagulation Therapy – 1 hour